Fosun International LTD Spero Therapeutics, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$9.01 - $12.55 $780,229 - $1.09 Million	-86,596 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$10.25 - $14.36 $171,851 - $240,759	-16,766 Reduced 16.22%	86,596 $962,000
Q1 2019 May 10, 2019	SELL	$6.26 - $13.31 $369,340 - $785,290	-59,000 Reduced 36.34%	103,362 $1.25 Million
Q4 2018 Jan 31, 2019	BUY	$5.69 - $11.28 $923,839 - $1.83 Million	162,362 New	162,362 $1.04 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $40.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.